SECOND-LINE THERAPY

Clinical trials for SECOND-LINE THERAPY explained in plain language.

Never miss a new study

Get alerted when new SECOND-LINE THERAPY trials appear

Sign up with your email to follow new studies for SECOND-LINE THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Drug duo aims to tackle tough lung cancers after first treatment fails

Disease control Ongoing

This trial tests whether combining sacituzumab tirumotecan (a targeted antibody-drug conjugate) with anlotinib (a multi-targeted pill) can shrink tumors or slow cancer growth in people with advanced non-squamous non-small cell lung cancer that has no known driver gene mutations. …

Matched conditions: SECOND-LINE THERAPY

Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Jul 16, 2026 00:00 UTC

SECOND-LINE THERAPY

Get alerted when new SECOND-LINE THERAPY trials appear

Drug duo aims to tackle tough lung cancers after first treatment fails